CI Investments Inc
CERE

CI Investments Inc’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

CI Investments Inc’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-139
Closed -$6K – 1306
2024
Q2 		$6K Sell
139
-8
-5% -$333 ﹤0.01% 1225
2024
Q1 		$6K Buy
+147
New +$6.17K ﹤0.01% 1252

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CI Investments Inc's CERE Position: Q3 2024 in Review

CI Investments Inc sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 139 shares — an estimated $6K sold.

CI Investments Inc first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $6K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • CI Investments Inc reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • CI Investments Inc sold 139 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $6K.
  • CI Investments Inc first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • CI Investments Inc's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $6K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on CI Investments Inc's 13F filing for Q3 2024, filed 12 Nov 2024.